Showing results (391-400 of 511) with videos related to
Sort By:
Pageof 52
JTO Clinical and Research Reports|September 2, 2025
Brief Report: Prospective Trial of Pembrolizumab Monotherapy in Metastatic NSCLC Evaluating Circulating Tumor DNA as a Surrogate Biomarker of ResponseIris van 't Erve, Isabelle Blanchard, Judy Y Pagtama, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 6, 2021
Impact of Low-Dose Computed Tomography Screening for Primary Lung Cancer on Subsequent Risk of Brain MetastasisChloe C Su, Julie T Wu, Joel W Neal, et al.Cancer Treatment and Research Communications|November 25, 2022
Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancerJacqueline V Aredo, Heather A Wakelee, Angela Bik-Yu Hui, et al.The American Journal of Physiology|May 11, 1992
Role of hepatic nerves in response of liver to intraportal glucose delivery in dogsB Adkins-Marshall, M J Pagliassotti, J R Asher, et al.Journal of Global Oncology|November 14, 2018
Comparison of Genomic Driver Oncogenes in Vietnamese Patients With Non-Small-Cell Lung Cancer in the United States and VietnamKim-Son H Nguyen, Henning Stehr, Li Zhou, et al.JTO Clinical and Research Reports|January 27, 2025
Afatinib and Necitumumab in EGFR-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase InhibitorsNathaniel J Myall, Jennifer G Whisenant, Joel W Neal, et al.Diabetes|February 27, 2010
Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivoChristopher J Ramnanan, Dale S Edgerton, Noelia Rivera, et al.The Journal of Pharmacology and Experimental Therapeutics|February 20, 2007
A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dogNoelia Rivera, Carrie A Everett-Grueter, Dale S Edgerton, et al.Journal of Endourology|April 14, 2018
In Vitro Comparison of a Novel Single Probe Dual-Energy Lithotripter to Current DevicesEvan C Carlos, Daniel A Wollin, Brenton B Winship, et al.JTO Clinical and Research Reports|November 19, 2025
DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed EGFR-Mutant Lung Cancer and Two Cases of Tarlatamab TherapyJacqueline V Aredo, Surbhi Singhal, Gerald J Berry, et al.Pageof 52